Join MediWales at BioWales in London to showcase Welsh life sciences and health technology organisations.
MediWales and Chambers Wales are delighted to announce our upcoming BioWales in London event on the 9th of March.
Welsh Life sciences is a thriving and dynamic sector and particularly in the last 2 years, there have been significant developments around clinical innovation, medtech and diagnostics. This event showcases exciting new innovations, and companies looking for investment and collaboration opportunities.
We will also have presentations from the Welsh NHS on how to engage with clinicians, collaborate on clinical studies and evaluations and support for regulatory compliance.
Tying in with Wales Week in London, this event will provide opportunities to strengthen the collaborative partnerships between the London and Wales.
Introduction and Welcome
MediWales Life Science Network for Wales:
Gwyn Tudor, CEO (Chair).
Blake Mogan LLP Relevant Realistic Solutions
Chambers Wales Welcome
Paul Slevin, President
Welsh Government Inward Investment
Julie Russell, Business Development Manager
Welsh Company Showcase
Midatech Pharma Bio-delivery of Medicines
Steve Ellul, VP of Business Development.
Jellagen Next Generation Collagen for Regenerative Medicine
Andrew Mearns Spragg, CSO.
CanSense Innovation in Cancer Diagnostics.
Airway Medical Suction & Oxygen Therapy Equipment
Glenn Kenworthy, CEO
BlueBox Optics Image guided surgery for Breast Cancer
Ron Yandle, CEO.
Creo Medical Advanced Energy in Therapeutic Endoscopy:
Richard Lawrence, Head of Service Operations.
Forth Female Hormone Mapping: Pioneering Women’s Health Through AI
Nicky Keay, Chief Medical Officer.
Glucose Republic Glucose Management through Digital and AI
David Haines, CEO.
Biophys Supporting Global Life Science from Wales
Michael Graz, CEO.
Funding and Finance
Panel discussion: support for companies on their investment journey and investment rounds.
Nick Rogers Chair:
Destiny Pharma Plc
Ian Smith CEO:
Bond Digital Health.
Alexander Leigh Senior Investment Executive
: Development Bank of Wales
Andrew Mearns-Spragg CSO:
Deputy Challenge Director: Innovate UK
Co-CEO and Head of Life Sciences: Saturn Investors
Working with the Welsh NHS
Chair: Andrew Davies
ABHI, Digital Health Lead
Tom James, Head of Innovation and Technology
Cardiff and Vale University Health Board
Mark Briggs, Innovation Lead.
Velindre Cancer Centre
Robyn Davies, Innovation Lead.
Simbec-Orion An agile CRO for complex clinical studies:
Julie Hodkinson, Senior Business Development Director
The Science Behind Clinical Trial Contract Research Services:
Tonia Smreczak: Managing Director
Networking Reception and Close
The event will be held at the Blake Morgan office in London.
Register for the event here
Abel & Imray